Media headlines about CareTrust REIT (NASDAQ:CTRE) have trended somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CareTrust REIT earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave headlines about the real estate investment trust an impact score of 45.8042014078147 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:
- Zacks Investment Research Upgrades CareTrust REIT, Inc. (NASDAQ:CTRE) to “Buy” (americanbankingnews.com)
- Brokerages Anticipate CareTrust REIT, Inc. (NASDAQ:CTRE) Will Announce Quarterly Sales of $31.59 Million (americanbankingnews.com)
- CareTrust REIT, Inc. (CTRE) Receives Consensus Rating of “Buy” from Brokerages (americanbankingnews.com)
- ETFs with exposure to CareTrust REIT, Inc. : July 14, 2017 (finance.yahoo.com)
- Hudson Bay Capital Issues Open Letter to Sabra Shareholders Urging Them to Vote against Proposed Acquisition of Care Capital (advfn.com)
Shares of CareTrust REIT (CTRE) opened at 18.19 on Wednesday. The company has a 50-day moving average price of $18.66 and a 200-day moving average price of $16.92. CareTrust REIT has a 52 week low of $12.70 and a 52 week high of $19.86.
The company also recently announced a quarterly dividend, which was paid on Friday, July 14th. Shareholders of record on Friday, June 30th were issued a $0.185 dividend. This represents a $0.74 annualized dividend and a dividend yield of 4.07%. The ex-dividend date of this dividend was Wednesday, June 28th.
CTRE has been the subject of a number of analyst reports. Canaccord Genuity increased their price objective on CareTrust REIT from $18.00 to $19.00 and gave the company a “buy” rating in a research note on Thursday, March 30th. BMO Capital Markets reissued a “buy” rating and set a $18.00 price objective on shares of CareTrust REIT in a research note on Wednesday, April 12th. Zacks Investment Research lowered CareTrust REIT from a “hold” rating to a “sell” rating in a research note on Tuesday, April 18th. TheStreet raised CareTrust REIT from a “c” rating to a “b” rating in a research note on Friday, May 5th. Finally, Raymond James Financial, Inc. reissued an “outperform” rating and set a $19.00 price objective (up previously from $17.00) on shares of CareTrust REIT in a research note on Wednesday, May 17th. Five analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $18.00.
COPYRIGHT VIOLATION NOTICE: “CareTrust REIT (CTRE) Earns News Impact Rating of 0.16” was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://sportsperspectives.com/2017/07/19/caretrust-reit-ctre-earns-news-impact-rating-of-0-16.html.
About CareTrust REIT
CareTrust REIT, Inc is a self-administered, self-managed real estate investment trust. The Company is engaged in the ownership, acquisition and leasing of healthcare-related properties. It makes investments in healthcare-related real estate assets. As of December 31, 2016, its real estate portfolio included 154 skilled nursing facilities (SNFs), SNF Campuses, assisted living facilities and independent living facilities.
Receive News & Ratings for CareTrust REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareTrust REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.